Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
Qiuju Zhang(Ministry of Education of the People's Republic of China), Chih‐Chuan Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), De‐Pei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Z. Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuang Zhou(Institute of High Energy Physics), Guanghua Liu(Nanjing University of Chinese Medicine), Hua Cai(University of California, Los Angeles), Wei Zheng(Army Medical University), Hou‐Zao Chen(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 388
Related Papers
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
|Circulation Research|2020|767
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy
|Circulation|2017|353
Mitochondria, endothelial cell function, and vascular diseases
|Frontiers in Physiology|2014|352
Repression of P66Shc Expression by SIRT1 Contributes to the Prevention of Hyperglycemia-Induced Endothelial Dysfunction
|Circulation Research|2011|274